bioAffinity Technologies Inc. – Filings and Transcripts

NASDAQ: BIAF
Share price (10/15/26): $3.96
Market cap (10/15/26): $5.081 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement

Shelf registration – amended

Shelf registration

Ownership Filter

Bigger Capital Fund L P

Oppenheimer John J.

Crumly Richard K.

News Filter

To Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026

To Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026

Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Announces Notification of Japanese Patent Allowance Covering Noninvasive CyPath® Lung and AI-Built Algorithm

Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026

Proxies Filter

Preliminary revised proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Correspondence with the SEC